Providing non-downloadable fiction books and fiction audiobooks via a website; publication of audio books; publication of books

Design, development and maintenance of software in the fields of genetic sequencing, genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering, antibody engineering, microbiology, pharmaceuticals, medicine, diagnostic preparations, immunopharmaceuticals, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assays; design, development and maintenance of software algorithms in the fields of biotechnology and modulating therapeutics; design, development and maintenance of software in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assays; design, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behaviours; gene regulation control services; gene regulatory network analysis; analysis, management and review of technical data; development and testing of computing methods, algorithms and software; design, development and maintenance of machine learning software; research in the field of artificial intelligence software; design and development of lab information management systems; design and development of software testing methods; providing non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; software as a service [SaaS] platforms and tools for collecting and interpreting clinical data; development and testing of computing methods, algorithms and software; platform as a service services; computer aided analysis services in the field of pharmaceuticals; database development and maintenance services; design and development of computer platforms; research and development services in the fields of pharmacogenetics, targeted pharmaceutical therapies and drug delivery platforms; research and development services in the field of regenerative medicines for the treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repair; research and development services in the fields of pharmaceuticals, immunopharmaceuticals, neoplastic diseases, modulating therapeutics, enhancers, super-enhancers, promoters, synthetic super enhancers in gene expression, DNA sequences, RNA sequences, fluorescent reporters, genetic cassettes, transgenes, gene therapy, drug delivery agents, vectors, diagnostic biomarker reagents, cell cultures, cell engineering, immunology and vaccines; research and development services in the fields of synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering and antibody engineering; research and development services for the treatment of cancers, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; research and development services for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological, biochemical, biomedical, bacteriological and pharmacological research, analysis, engineering and development services; biological laboratory services; cell engineering services, namely cell suppression, cell activation, and cell programming and reprogramming; culturing of cells for scientific or medical research purposes; contract research services relating to enhancers, and super-enhancers and promoters; drug development services; development of gene-based medicines; providing information about medical research in the fields of biopharmaceuticals, immunology, cell engineering and immunoassays; scientific services relating to the isolation and cultivation of human tissues and cells; laboratory services namely, research, analysis, characterising, development and production of therapeutics for the treatment of neoplastic diseases, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; genetic engineering services; genetic sequencing and genotyping services; RNA sequencing services; analysis services regarding the safety and efficacy of new pharmaceuticals; diagnostic services in the field of immunology; polymerase chain reaction [PCR] services; preparation of reports in the field of biotechnology; testing of human tissues and stem cells for scientific or medical research purposes; use of biomarkers to investigate human immune response for medical purposes; design, research, analysis and engineering services relating to genetic cassettes; design and engineering services relating to genomic safe harbours, recombination sites, minimal promoters, insulators, splicing control elements, gene terminators, UTRs, capsids, fusion linkers, translational control elements and transcriptional units; RNA sequence optimisation services; evaluation services relating to RNA quality; translational control services in the field of gene expression; design of therapeutic payloads; consultancy, information and advisory services relating to all of the aforesaid services.

Loyalty program and incentive award program payment processing services; providing financial information about retail products; financial transaction services, namely, electronic transfer of virtual currencies; electronic wallet services, namely payment and storage services provided via an electronic wallet; electronic transfer of cryptocurrencies, digital currencies and virtual currencies; providing financial information in the fields of digital assets, digital tokens, crypto-tokens, utility tokens, non-fungible tokens (NFTs), digital collectibles, crypto-collectibles, cryptocurrencies, digital currencies and virtual currencies; blockchain-based payment verification services; cryptocurrency exchange services; financial services, namely, providing a virtual currency for use by members of an on-line community via a global computer network; issuance and payment processing of loyalty points for purchase of the goods and services of others via an incentive award program.

Providing temporary use of online non-downloadable software for facilitating electronic commerce transactions; providing temporary use of online non-downloadable software for managing and administering customer loyalty programs and incentive rewards programs; providing temporary use of online non-downloadable software for administering, conducting, managing, and facilitating loyalty programs; providing temporary use of online non-downloadable software for issuing digital assets, digital tokens, crypto-tokens, utility tokens, cryptocurrencies, digital currencies and virtual currencies as part of a customer loyalty program; providing temporary use of online non-downloadable software for storing, accessing, compiling and delivering financial information and data using blockchain technology; providing temporary use of online non-downloadable software for verifying, recording, validating, and managing transactions using blockchain technology; providing temporary use of online non-downloadable software for creating, issuing, viewing, distributing, trading, storing, sending, receiving, accepting, and transmitting digital assets, digital tokens, crypto-tokens, utility tokens, non-fungible tokens (NFTs), digital collectibles, crypto-collectibles, cryptocurrencies, digital currencies and virtual currencies; providing temporary use of online non-downloadable software for electronic funds transfer; providing temporary use of online non-downloadable software for use as a cryptocurrency wallet; providing temporary use of online non-downloadable software for use as an electronic wallet; providing temporary use of online non-downloadable software for creating and managing electronic wallets; providing temporary use of online non-downloadable software for managing and validating transactions involving digital assets, digital tokens, crypto-tokens, utility tokens, non-fungible tokens (NFTs), digital collectibles, crypto-collectibles, cryptocurrencies, digital currencies and virtual currencies; providing temporary use of online non-downloadable software for the electronic distribution of digital assets, digital tokens, crypto-tokens, and utility tokens with cash equivalents in the nature of cryptocurrency; providing temporary use of online non-downloadable software for the electronic transmission of digital currency in the nature of digital assets, digital tokens, crypto-tokens, and utility tokens with cash equivalents in the nature of cryptocurrency; computer security services in the nature of providing user authentication, user verification services and user identification verification services; providing user authentication services using blockchain based software technology for cryptocurrency transactions; providing user authentication services using technology for e-commerce transactions, digital currency payment transactions, and electronic funds transfers; provision of online non-downloadable software for enabling cryptographic security of electronic transmissions across computer networks; electronic storage of digital currency, namely, digital assets, digital tokens, crypto-tokens, and utility tokens with cash equivalents in the nature of cryptocurrency; providing temporary use of online non-downloadable software for participating and voting in decentralized autonomous organizations; providing temporary use of online non-downloadable software for management and governance of decentralized autonomous organizations; providing temporary use of non-downloadable web-based decentralized applications (DApps) for cryptocurrency transactions.

Software as a service (SAAS) services featuring software for analyzing and processing visual medical data; software as a service (SAAS) services featuring software incorporating artificial intelligence algorithms for analyzing and processing visual medical data; software as a service (SAAS) services featuring software for monitoring health and failure modes of industrial machines in the fields of transportation, energy, aerospace and aviation; software as a service (SAAS) services featuring software incorporating artificial intelligence algorithms for monitoring health and failure modes of industrial machines in the fields of transportation, energy, aerospace and aviation; software as a service (SAAS) services featuring software for scheduling medical tasks, namely, surgery, diagnosis, testing, administration of medication, and examination of patients; software as a service (SAAS) services featuring software for analyzing and processing visual data of industrial machines in the fields of energy, transportation, aerospace, and aviation; software as a service (SAAS) services featuring software incorporating artificial intelligence algorithms for analyzing and processing visual data of industrial machines in the fields of energy, transportation, aerospace, and aviation; all these services are not related to the prevention, treatment, surgery, diagnosis and monitoring of ophthalmic diseases, vision disorders, visual dysfunctions and/or the measurement of visual acuity.